aod9604 uk AOD 9604 5MG 5MG aod9604 latest research AOD 9604

A less than optimal production of red blood cells may lead to a lowered oxygen carrying capacity of the blood, resulting in poor performance and premature fatigue

Any findings referenced are derived from experimental models and controlled research settings and should not be interpreted as therapeutic or clinical outcomes

Storage & Stability AOD-9604 is supplied as a lyophilised peptide

Quality control measures are implemented throughout the compounding process to verify the accuracy of ingredient measurements, sterility of the final product, and absence of particulate matter or other contaminants

The canonical structure has a quinolinium core with strategic substitutions that give it unique electronic and steric properties

Inhibits Lipogenesis AOD-9604 suppresses the formation of new fat cells by downregulating enzymes involved in fat synthesis